News

Our recent paper in The Lancet Neurology shows that simvastatin can improve cognitive function in people with secondary progressive multiple sclerosis (SPMS). Read more about this work on UCL news or on medicalxpress.com, and about the next phase of the statin trials on the guardian website. Download the paper here or click read more. 

 

Dennis Chan, Sophie Binks, Jennifer M Nicholas, Chris Frost, M Jorge Cardoso, Sebastien Ourselin, David Wilkie, Richard Nicholas, Jeremy Chataway, Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial, (2017) The Lancet Neurology